Context Therapeutics CNTX
NASDAQ CNTX
$0.17 +0.00 (+0.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Context Therapeutics (CNTX) Liabilities and Shareholders Equity (2020 - 2026)

Updated

Context Therapeutics (CNTX) posted Liabilities and Shareholders Equity of $36.54 million for Q3 2026, down 53.9% from $79.23 million a year earlier and down 20.8% from the prior quarter.

Analysis

Context Therapeutics (CNTX) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Context Therapeutics' Liabilities and Shareholders Equity came in at $68.49 million, down 30.2% from FY2024.

  • Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 171.1% (FY2020 to FY2025).
  • In prior years, Context Therapeutics' Liabilities and Shareholders Equity was $98.13 million in FY2024 (+510.9%), $16.06 million in FY2023 (-57.7%), $37.97 million in FY2022 (-26.0%) and $51.31 million in FY2021.
  • The Q3 2026 figure stands as the lowest quarterly Liabilities and Shareholders Equity since Q1 2024.
  • On a year-over-year basis, Liabilities and Shareholders Equity has declined in each of the last six quarters, with growth averaging 132.6% over the last eight quarters.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q1 2025, with growth of 741.2%; the weakest was Q1 2024, with a decline of 65.4%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $46.13 million (Q2 2026), $58.86 million (Q1 2026) and $68.49 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 2.15 Mn
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 148.07 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 197.43 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 147.68 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 132.77 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 51.41 Bn
9 Gsk 193.54 Bn 176.38 Bn - 94.88 Bn
10 Context Therapeutics 15.24 Mn -182.70 Mn - 36.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 36.54 Mn
Jun 30, 2026 46.13 Mn
Mar 31, 2026 58.86 Mn
Dec 31, 2025 68.49 Mn
Sep 30, 2025 79.23 Mn
Jun 30, 2025 87.15 Mn
Mar 31, 2025 92.97 Mn
Dec 31, 2024 98.13 Mn
Sep 30, 2024 86.33 Mn
Jun 30, 2024 102.71 Mn
Mar 31, 2024 11.05 Mn
Dec 31, 2023 16.06 Mn
Sep 30, 2023 22.99 Mn
Jun 30, 2023 27.76 Mn
Mar 31, 2023 31.97 Mn
Dec 31, 2022 37.97 Mn
Sep 30, 2022 42.08 Mn
Jun 30, 2022 44.70 Mn
Mar 31, 2022 47.03 Mn
Dec 31, 2021 51.31 Mn
API Access

Context Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CNTX&period=max&api_key=YOUR_API_KEY